|
KIAA0776 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.67339999973737E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.39409999497542E-08 |
| Normal-vs-Stage2 |
1.251560E-01 |
| Normal-vs-Stage3 |
1.052630E-01 |
| Normal-vs-Stage4 |
5.552800E-01 |
| Stage1-vs-Stage2 |
1.498380E-01 |
| Stage1-vs-Stage3 |
5.922000E-02 |
| Stage1-vs-Stage4 |
1.335160E-01 |
| Stage2-vs-Stage3 |
8.737400E-01 |
| Stage2-vs-Stage4 |
7.407800E-01 |
| Stage3-vs-Stage4 |
8.064200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13029999979386E-07 |
| Normal-vs-AfricanAmerican |
1.317370E-03 |
| Normal-vs-Asian |
2.897800E-03 |
| Caucasian-vs-AfricanAmerican |
6.414600E-01 |
| Caucasian-vs-Asian |
7.009800E-01 |
| AfricanAmerican-vs-Asian |
6.184400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2421000006313E-08 |
| Normal-vs-Female |
5.533700E-02 |
| Male-vs-Female |
1.858730E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.083600E-02 |
| Normal-vs-Extreme_Weight |
4.40110170529806E-11 |
| Normal-vs-Obese |
2.640300E-03 |
| Normal-vs-Extreme_Obese |
1.001570E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.297800E-02 |
| Normal_Weight-vs-Obese |
9.612200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.530200E-01 |
| Extreme_Weight-vs-Obese |
3.895300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.606200E-02 |
| Obese-vs-Extreme_Obese |
9.695000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.415600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.636600E-04 |
| Normal-vs-Age(61-80Yrs) |
6.41020000413661E-08 |
| Normal-vs-Age(81-100Yrs) |
3.79710000000255E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.903400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.145200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.369500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.741900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.177420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.457600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.28040003231223E-09 |
| Normal-VS-Type2 PRCC |
1.264320E-02 |
| Normal-VS-KIRP CIMP |
2.210400E-01 |
| Normal-VS-Unclassified PRCC |
9.655400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.566300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.203000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.912250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.024600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.401200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.133800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17739999999189E-05 |
| Normal-vs-N1 |
8.101800E-01 |
| Normal-vs-N2 |
1.586970E-04 |
| N0-vs-N1 |
4.717600E-02 |
| N0-vs-N2 |
3.699800E-01 |
| N1-vs-N2 |
1.446160E-01 |
|
|
